Search research articles
Contact Us
Filters
Showing results (31-40 of 149) with videos related to
Page
of 15
Sort By:
Therapie
|
October 17, 1998
[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]
O Rascol, C Brefel-Courbon, O Blin
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 15, 2003
Weight gain profiles of new anti-psychotics: public health consequences
S Tardieu, J Micallef, S Gentile, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 1, 1992
Nociceptive threshold and physical activity
R Guieu, O Blin, J Pouget, et al.
Revue Neurologique
|
January 1, 1992
[Rademaker and Garcin syndrome associated with pallidal calcifications]
G Masson, O Blin, J Pouget, et al.
Acta Psychiatrica Scandinavica
|
December 17, 2003
Amphetamine-like stimulant cessation in an abusing patient treated with bupropion
S Tardieu, Y Poirier, J Micallef, et al.
Fundamental & Clinical Pharmacology
|
January 1, 1992
Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affinity uptake systems
D Samuel, O Blin, N Dusticier, et al.
L'Encephale
|
February 18, 2003
[From neuroleptics to antipsychotics: the cognitive and emotional impact]
O Blin, E Fakra, S Tardieu, et al.
Therapie
|
December 1, 2000
[Public health networks: practical aspects and contribution to clinical research. Round table no. 2. XV]
J Micallef, B Bégaud, O Mariotte, et al.
Clinical Neuropharmacology
|
October 1, 1990
Akathisia, motility, and locomotion in healthy volunteers
O Blin, M Durup, J Pailhous, et al.
L'Encephale
|
February 11, 2000
[Construction and validation of visual analogue scale for risk assessment]
B Sicard, E Jouve, O Blin, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 149) with videos related to
Sort By:
Page
of 15
Therapie
|
October 17, 1998
[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]
O Rascol, C Brefel-Courbon, O Blin
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 15, 2003
Weight gain profiles of new anti-psychotics: public health consequences
S Tardieu, J Micallef, S Gentile, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 1, 1992
Nociceptive threshold and physical activity
R Guieu, O Blin, J Pouget, et al.
Revue Neurologique
|
January 1, 1992
[Rademaker and Garcin syndrome associated with pallidal calcifications]
G Masson, O Blin, J Pouget, et al.
Acta Psychiatrica Scandinavica
|
December 17, 2003
Amphetamine-like stimulant cessation in an abusing patient treated with bupropion
S Tardieu, Y Poirier, J Micallef, et al.
Fundamental & Clinical Pharmacology
|
January 1, 1992
Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affinity uptake systems
D Samuel, O Blin, N Dusticier, et al.
L'Encephale
|
February 18, 2003
[From neuroleptics to antipsychotics: the cognitive and emotional impact]
O Blin, E Fakra, S Tardieu, et al.
Therapie
|
December 1, 2000
[Public health networks: practical aspects and contribution to clinical research. Round table no. 2. XV]
J Micallef, B Bégaud, O Mariotte, et al.
Clinical Neuropharmacology
|
October 1, 1990
Akathisia, motility, and locomotion in healthy volunteers
O Blin, M Durup, J Pailhous, et al.
L'Encephale
|
February 11, 2000
[Construction and validation of visual analogue scale for risk assessment]
B Sicard, E Jouve, O Blin, et al.
Page
of 15